The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Open accessAbstract
A potent, synthetic cannabinoid was radiolabeled and used to characterize and precisely localize cannabinoid receptors in slide-mounted sections of rat brain and pituitary. Assay conditions for 3H-CP55,940 binding in Tris-HCl buffer with 5% BSA were optimized, association and dissociation rate constants determined, and the equilibrium dissociation constant (Kd) calculated (21 nM by liquid scintillation counting, 5.2 nM by quantitative autoradiography). The results of competition studies, using several synthetic cannabinoids, add to prior data showing enantioselectivity of binding and correlation of in vitro potencies with potencies in biological assays of cannabinoid actions. Inhibition of binding by guanine nucleotides was selective and profound: Nonhydrolyzable analogs of GTP and GDP inhibited binding by greater than 90%, and GMP and the nonhydrolyzable ATP analog showed no inhibition. Autoradiography showed great heterogeneity of binding in patterns of labeling that closely conform to cytoarchitectural and functional domains. Very dense 3H-CP55,940 binding is localized to the basal ganglia (lateral caudate-putamen, globus pallidus, entopeduncular nucleus, substantia nigra pars reticulata), cerebellar molecular layer, innermost layers of the olfactory bulb, and portions of the hippocampal formation (CA3 and dentate gyrus molecular layer). Moderately dense binding is found throughout the remaining forebrain. Sparse binding characterizes the brain stem and spinal cord. Densitometry confirmed the quantitative heterogeneity of cannabinoid receptors (10 nM 3H-CP55,940 binding ranged in density from 6.3 pmol/mg protein in the substantia nigra pars reticulata to 0.15 pmol/mg protein in the anterior lobe of the pituitary). The results suggest that the presently characterized cannabinoid receptor mediates physiological and behavioral effects of natural and synthetic cannabinoids, because it is strongly coupled to guanine nucleotide regulatory proteins and is discretely localized to cortical, basal ganglia, and cerebellar structures involved with cognition and movement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are localized to the central nervous system (CNS) and the periphery. CB1 receptors are found in sites associated with pain processing, including the periaqueductal gray (PAG),8 rostral ventromedial medulla (RVM),8 thalamus,9 dorsal root ganglia (DRG),10 amygdala,8 and cortex8.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Self-citationThe organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Baserga, R. (1967) · JAMA · doi:10.1001/jama.1967.03130250093034 · Cited by 1,146
Hypoplasia of cerebellar vermal lobules VI and VII in autism
Courchesne, E., Yeung-Courchesne, R., Hesselink, J. R., & Jernigan, T. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182102 · Cited by 1,058
Rogers, A. W. (1967) · Medical Entomology and Zoology · Cited by 1,026
Kelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90067-7 · Cited by 888
Research works printed but not linked: 3
- Harris LS, Dewey WL, Razdan RK (1977) Cannabis. Its chemistry, pharmacology, and toxicology. In: Handbook of experimental phar- macology (Martin WR, ed), pp 37 l-%29. New York: Springer.
- Margulies JE, Hammer RP (1991) THC alters cerebral metabolism in limbic and cortical regions in a biphasic, dose-dependent manner. Ale Drug Res, in press.
- Pertwee RG (1985) Cannabis. In: Psychopharmacology 2, Pt 1: Pre- clinical psychopharmacology (Grahame-Smith DG, Cowan PJ, eds), pp 364-39 1. Amsterdam: Elsevier.
Cited by
Sorted by citations
Items 301–400 of 1,009
Motor actions of cannabinoids in the basal ganglia output nuclei
Sañudo-Peña, M. C., Tsou, K., & Walker, J. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00293-3 · Cited by 145
The endocannabinoid system: An emotional buffer in the modulation of memory function
Morena, M., & Campolongo, P. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.12.010 · Cited by 153
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
More, S. V., & Choi, D. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0012-0 · Cited by 148
A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain
Ong, W.-Y., & Mackie, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00025-1 · Cited by 145
Acute Neuronal Injury, Excitotoxicity, and the Endocannabinoid System
van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bär, P. R., Nicolay, K., Veldink, G. A., Marzo, V. D., & Vliegenthart, J. F. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:317 · Cited by 143
Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.053 · Cited by 142
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction
de Oliveira Alvares, L., Pasqualini Genro, B., Diehl, F., Molina, V. A., & Quillfeldt, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.005 · Cited by 143
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism
Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi‐Agrò, A., & Calabresi, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01759.x · Cited by 143
Riebe, C. J. N., & Wotjak, C. T. (2011) · Stress · doi:10.3109/10253890.2011.586753 · Cited by 149
Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 141
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Viveros, M., Marco, E. M., Llorente, R., & López‐Gallardo, M. (2007) · Neural Plasticity · doi:10.1155/2007/52908 · Cited by 151
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 146
Gatley, S. J., Lan, R., Pyatt, B. E., Gifford, A. N., Volkow, N. D., & Makriyannis, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00690-5 · Cited by 140
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
Freedland, C. S., Poston, J. S., & Porrino, L. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00359-2 · Cited by 141
Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 139
Basavarajappa, B. S., Cooper, T. B., & Hungund, B. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00175-9 · Cited by 140
Endocannabinoids in cognition and dependence
Lichtman, A. H., Varvel, S. A., & Martin, B. R. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0351 · Cited by 135
Abnormal cerebellar morphometry in abstinent adolescent marijuana users
Lisdahl, K. M., Nagel, B. J., & Tapert, S. F. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.12.004 · Cited by 141
Lin, S., Khanolkar, A. D., Fan, P., Goutopoulos, A., Qin, C., Papahadjis, D., & Makriyannis, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970257g · Cited by 142
Melis, T., Succu, S., Sanna, F., Boi, A., Argiolas, A., & Melis, M. R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.012 · Cited by 138
Martin, W. J., Tsou, K., & Walker, J. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00044-5 · Cited by 138
Kurz, A., Double, K. L., Lastres‐Becker, I., Tozzi, A., Tantucci, M., Bockhart, V., von Bonin, M., García-Arencibia, M., Nuber, S., Schlaudraff, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011464 · Cited by 137
Dow-Edwards, D. L., MacMaster, F. P., Peterson, B. S., Niesink, R. J. M., Andersen, S. L., & Braams, B. R. (2019) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2019.106834 · Cited by 160
Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 148
Vaughan, C. W., McGregor, I. S., & Christie, M. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702636 · Cited by 137
Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.006 · Cited by 136
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J., & Chen, C. (2014) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 143
Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 139
Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol
Wise, L. E., Thorpe, A. J., & Lichtman, A. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.31 · Cited by 136
Hentges, S. T., Low, M. J., & Williams, J. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2769-05.2005 · Cited by 136
Maejima, T., Ohno‐Shosaku, T., & Kano, M. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00241-3 · Cited by 139
Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain
Biegon, A. R., & Kerman, I. A. (2001) · NeuroImage · doi:10.1006/nimg.2001.0939 · Cited by 138
Finn, D. P., Jhaveri, M. D., Beckett, S. R. G., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00235-1 · Cited by 136
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138
Maranduba, C. M. D. C., de Castro, S. B. R., de Souza, G. T., Rossato, C., da Guia, F. C., Valente, M. A. S., Rettore, J. V. P., Maranduba, C. P., de Souza, C. M., do Carmo, A. M. R., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/931574 · Cited by 137
Endocrine Effects of Marijuana
Brown, T. T., & Dobs, A. S. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06008.x · Cited by 134
The endogenous cannabinoid system and the basal ganglia
Romero, J., Lastres‐Becker, I., de Miguel, R., Berrendero, F., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00253-x · Cited by 134
Villares, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.012 · Cited by 134
Regulation of neuronal communication by G protein‐coupled receptors
Huang, Y., & Thathiah, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.007 · Cited by 139
González, S. R., Fernández‐Ruíz, J., Sparpaglione, V., Parolaro, D., & Ramos, J. A. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00186-7 · Cited by 132
Alzheimer's disease; taking the edge off with cannabinoids?
Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 132
Farquhar-Smith, P. W., Jaggar, S., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 132
Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
Varvel, S. A., Anum, E. A., & Lichtman, A. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2121-2 · Cited by 136
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.006 · Cited by 142
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice
Heß, C., Schoeder, C. T., Pillaiyar, T., Madea, B., & Müller, C. E. (2016) · Forensic Toxicology · doi:10.1007/s11419-016-0320-2 · Cited by 134
Elston, G. N., Tweedale, R., & Rosa, M. G. P. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991206)415:1 · Cited by 90
Cannabinoid Receptor Localization in Brain: Relationship to Motor and Reward Systems
Herkenham, M. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25953.x · Cited by 133
Self-citationControl of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 134
Adenosine–cannabinoid receptor interactions. Implications for striatal function
Ferré, S., Lluı́s, C., Justinová, Z., Quiroz, C., Orrù, M., Navarro, G., Canela, E. I., Franco, R., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00723.x · Cited by 129
Ignatowska‐Jankowska, B. M., Ghosh, S., Crowe, M. S., Kinsey, S. G., Niphakis, M. J., Abdullah, R. A., Tao, Q., O' Neal, S. T., Walentiny, D. M., Wiley, J. L., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12298 · Cited by 128
Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens
Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 128
Spanagel, R. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/rspanagel · Cited by 127
Biphasic effects of THC in memory and cognition
Calabrese, E. J., & Rubio‐Casillas, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12920 · Cited by 132
Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_144 · Cited by 132
Vinod, K. Y., Arango, V., Xie, S., Kassir, S. A., Mann, J. J., Cooper, T. B., & Hungund, B. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.033 · Cited by 127
Takahashi, R. N., Pamplona, F. A., & Fernandes, M. S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.049 · Cited by 127
Schacht, J. P., Hutchison, K. E., & Filbey, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.92 · Cited by 126
García‐Gutiérrez, M. S., Ortega-Álvaro, A., Busquets-García, A., Pérez‐Ortiz, J. M., Caltana, L. R., Ricatti, M. J., Brusco, A., Maldonado, R. J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.034 · Cited by 126
Suárez, J., Bermúdez‐Silva, F. J., Mackie, K., Ledent, C. A., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21774 · Cited by 126
Blair, R. E., Deshpande, L. S., Sombati, S., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100354 · Cited by 124
Hohmann, A. G., Tsou, K., & Walker, J. M. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.2.575 · Cited by 127
Barnett‐Norris, J., Lynch, D. L., & Reggio, P. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.040 · Cited by 126
The endocannabinoid system is modulated in response to spinal cord injury in rats
García‐Ovejero, D., Arévalo‐Martín, Á., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., Watanabe, M., Guaza, C., Marzo, V. D., & Molina‐Holgado, E. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.015 · Cited by 128
Sim‐Selley, L. J., & Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035618 · Cited by 125
Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids
Gammon, C. M., Freeman, G. M., Xie, W., Petersen, S. L., & Wetsel, W. C. (2005) · Endocrinology · doi:10.1210/en.2004-1672 · Cited by 126
Wang, W., Sun, D., Pan, B., Roberts, C. J., Sun, X., Hillard, C. J., & Liu, Q.-S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.99 · Cited by 127
DiPatrizio, N. V., & Simansky, K. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1171-08.2008 · Cited by 129
Cota, D. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.764 · Cited by 134
Mailleux, P., & Vanderhaeghen, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09807.x · Cited by 122
Endocannabinoid signaling and food addiction
D’Addario, C., Bonaventura, M. V. M. D., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, R., Cifani, C., & Maccarrone, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.008 · Cited by 124
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
Laere, K. V., Casteels, C., Lunskens, S., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.009 · Cited by 120
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition
Hájos, N., & Freund, T. F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00149-4 · Cited by 122
Hohmann, A. G., Martin, W. J., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00196-d · Cited by 120
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Aso, E., Palomer, E., Juvés, S., Maldonado, R. J., Muñoz, F. J., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111862 · Cited by 122
Gómez, O., Sanchez‐Rodriguez, A., Le, M., Sanchez‐Caro, C., Molina‐Holgado, F., & Molina‐Holgado, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01414.x · Cited by 120
Salio, C., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00584-x · Cited by 123
Role of Cannabinoid Receptors in Memory Storage
Hampson, R. E., & Deadwyler, S. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0223 · Cited by 119
Forget, B., Coen, K. M., & Foll, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1569-5 · Cited by 121
Muntoni, A. L., Pillolla, G., Melis, M., Perra, S., Gessa, G. L., & Pistis, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04759.x · Cited by 121
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120
Intrinsic and integrative properties of substantia nigra pars reticulata neurons
Zhou, F., & Lee, C. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.061 · Cited by 116
The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
Tschöp, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., Dattilo, J. R., Lentsch, A. B., Tschöp, M. H., & Caldwell, C. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900203 · Cited by 119
The Neuroanatomical Organization of the Basal Ganglia
Gerfen, C. R., & Bolam, J. P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00001-9 · Cited by 119
Endocannabinoids and cannabinoid receptor genetics
Onaivi, E. S., Leonard, C. M., Ishiguro, H., Zhang, P. W., Lin, Z., Akinshola, B. E., & Uhl, G. R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00007-2 · Cited by 119
Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1377 · Cited by 117
Casarotto, P. C., Terzian, A. L. B., Aguiar, D. C., Zangrossi, H., Guimarães, F. S., Wotjak, C. T., & Moreira, F. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.207 · Cited by 117
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
Karschner, E. L., Darwin, W. D., McMahon, R. P., Liu, F., Wright, S., Goodwin, R. S., & Huestis, M. A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.318 · Cited by 117
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119
Modulation of the serotonin system by endocannabinoid signaling
Haj‐Dahmane, S., & Shen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.016 · Cited by 126
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Bermúdez‐Silva, F. J., Cardinal, P., & Cota, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408458 · Cited by 126
Schoeder, C. T., Heß, C., Madea, B., Meiler, J., & Müller, C. E. (2018) · Forensic Toxicology · doi:10.1007/s11419-018-0415-z · Cited by 121
Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway
Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 122
Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
Steiner, H., Bonner, T. I., Zimmer, A. M., Kitai, S. T., & Zimmer, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5786 · Cited by 119
Cannabinoid Transmission and Pain Perception
Martin, B. R., & Lichtman, A. H. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0218 · Cited by 121
Griffin, G., Atkinson, P. J., Showalter, V. M., Martin, B. R., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37418-x · Cited by 118
Lastres‐Becker, I., Hansen, H. H., Berrendero, F., de Miguel, R., Pérez‐Rosado, A., Manzanares, J., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Synapse · doi:10.1002/syn.10054 · Cited by 116
Wu, X., & French, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00140-9 · Cited by 116
McGaraughty, S., Chu, K. L., Bitner, R. S., Martino, B. R., Kouhen, R. E., Han, P., Nikkel, A. L., Burgard, E. C., Faltynek, C. R., & Jarvis, M. F. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00433.2003 · Cited by 116
Abood, M. E., Rizvi, G., Sallapudi, N., & McAllister, S. D. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02065-1 · Cited by 116
Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., & Casellas, P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12171-2 · Cited by 115
Metadata
- Authors
- Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Herkenham, M
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1991-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 563-583
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6575215
- OpenAlex
- W1836729582
- Cited by
- 2,159
- References
- 65
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 43 · 2023: 56 · 2022: 64 · 2021: 65 · 2020: 84 · 2019: 61 · 2018: 74 · 2017: 70 · 2016: 70 · 2015: 95 · 2014: 77 · 2013: 74 · 2012: 86
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, receptor localization, receptor density, G protein coupling, enantioselectivity, basal ganglia, cerebellar molecular layer, olfactory bulb, hippocampus, substantia nigra pars reticulata, pituitary gland, rat brain
- MeSH terms
- Animals, Autoradiography, Brain, Buffers, Cannabinoids, Cyclohexanols, Male, Rats, Inbred Strains, Receptors, Drug, Serum Albumin, Bovine, Temperature, Time Factors, Tissue Distribution, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review